NCT00513409View on ClinicalTrials.gov

Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule

PHASE2CompletedINTERVENTIONAL
Enrollment

163

Participants

Timeline

Start Date

August 22, 2007

Primary Completion Date

February 20, 2008

Study Completion Date

August 28, 2008

Conditions
Infections, Streptococcal
Interventions
BIOLOGICAL

Synflorix

Intramuscular injection, 1 or 2 doses

BIOLOGICAL

Infanrix Hexa

1 Intramuscular injection

BIOLOGICAL

Havrix

1 Intramuscular injection

Trial Locations (1)

Unknown

GSK Investigational Site, Santiago

Sponsors

Lead Sponsor

GlaxoSmithKline
All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY

NCT00513409 - Assess Reacto- and Immunogenicity of Pneumococcal Conjugate Vaccine When Given as Booster or a 2 Dose Catch up Schedule | Biotech Hunter | Biotech Hunter